RapidArc planning and delivery in patients with locally advanced head-and-neck cancer undergoing chemoradiotherapy.

@article{Doornaert2011RapidArcPA,
  title={RapidArc planning and delivery in patients with locally advanced head-and-neck cancer undergoing chemoradiotherapy.},
  author={Patricia A. H. Doornaert and Wilko F A R Verbakel and Michael Bieker and Ben J. Slotman and Suresh Senan},
  journal={International journal of radiation oncology, biology, physics},
  year={2011},
  volume={79 2},
  pages={
          429-35
        }
}
PURPOSE Volumetric modulated arc therapy (RapidArc, Varian Medical Systems) permits the delivery of highly conformal dose distributions. We studied planning and delivery in patients who underwent RapidArc for locally advanced head-and-neck cancer (HNC). METHODS AND MATERIALS A total of 35 consecutive patients who completed RapidArc with concurrent chemotherapy for Stages III-IV tumors of the oro- and hypopharynx/larynx in our center were identified. All underwent bilateral neck irradiation… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 45 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 34 REFERENCES

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

  • JP Pignon, A Maitre, E Maillard
  • Radiother Oncol
  • 2009
2 Excerpts

Single-arc IMRT? Phys Med Biol 2009;54: N9–N20. RapidArc in locally advanced head and neck cancer d P

  • T Bortfeld, S. Webb
  • DOORNAERT et
  • 2009
2 Excerpts

Similar Papers

Loading similar papers…